FDA and FTC Warn 7 Companies Against Marketing Unapproved Coronavirus Therapies
On March 6, 2020, the U.S. Food and Drug Administration (FDA) and the U.S. Federal…
Browsing: Federal
Several Insurers Waive Cost-Sharing for Coronavirus Testing
As of March 10, 2020, over 100,000 people have been infected with and over 4,000…
FDA Issues Report to Congress on CBD Products
On March 5, 2020, the U.S. Food and Drug Administration (FDA) issued a report to…
New Report by Digital Citizens Alliance Analyzes the Growing CBD Industry and the Need for Regulation
On March 5, 2020, Digital Citizens Alliance, a non-profit organization that is consumer-oriented and focused…
Insurers Oppose Price Transparency Rule and Request an Implementation Delay
On November 15, 2019, the Trump Administration released a proposed rule that would require health…
Supreme Court Grants Certiorari in Texas v. Azar
On March 2, 2020, the Supreme Court of the United States granted certiorari in Texas…
Copay Coupon App Exposes Personal Medical Information to Advertisers
A recent article by Consumer Reports explored a controversy involving the GoodRx application, which allegedly…
Aimed Alliance Responds to the Administration’s Notice of Benefit and Payment Parameters for 2021
On January 31, 2020, the Centers for Medicare & Medicaid Services (CMS) released the proposed…
Appeals Court Invalidates Medicaid Work Requirements in Arkansas
On February 14, 2020, the U.S. Court of Appeals for the D.C. Circuit issued its…
CMS Seeks Additional Information on Georgia’s Sec. 1332 Waiver Application
On February 6, 2020, the Centers for Medicare & Medicaid Services (CMS) sent a letter…